MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GERN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Geron (GERN) Ownership - Who owns Geron?

Geron Corp is a biopharmaceutical company focused on blood cancers... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
258
Web
https://www.geron.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
776.24M
P/E Ratio
N/A
Total Cash
312.4M
Projected Growth
N/A
Total Debt
122.07M
Revenue
196.12M
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash/Share
0.49
Total Debt/Equity
N/A
Revenue/Share
0.29 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GERN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GERN
A.I. Advisor
published General Information

General Information

a developer of therapeutic products for cancer

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
258
Web
https://www.geron.com